GLSI
Income statement / Annual
Last year (2023), Greenwich LifeSciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Greenwich LifeSciences, Inc.'s net income was -$8.89 M.
See Greenwich LifeSciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3,612.00 |
$3,612.00 |
$3,612.00 |
$3,609.00 |
$3,607.00 |
$3,607.00 |
$3,607.00 |
| Gross Profit |
-$3,612.00 |
-$3,612.00 |
-$3,612.00 |
-$3,609.00 |
-$3,607.00 |
-$3,607.00 |
-$3,607.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$7.70 M
|
$6.48 M
|
$3.56 M
|
$1.06 M
|
$2.61 M
|
$1.27 M
|
$1.22 M
|
| General & Administrative
Expenses |
$1.63 M
|
$1.56 M
|
$1.04 M
|
$806,188.00
|
$818,887.00
|
$419,639.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.63 M
|
$1.56 M
|
$1.04 M
|
$806,188.00
|
$818,887.00
|
$419,639.00
|
$346,812.00
|
| Other Expenses |
-$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$9.33 M |
$8.04 M |
$4.60 M |
$1.86 M |
$3.43 M |
$1.69 M |
$1.57 M |
| Cost And Expenses |
$9.33 M |
$8.04 M |
$4.60 M |
$1.86 M |
$3.43 M |
$1.69 M |
$1.57 M |
| Interest Income |
$436,063.00 |
$215,017.00 |
$27,367.00 |
$832.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3,612.00
|
$3,612.00
|
$3,612.00
|
$3,609.00
|
$3,607.00
|
$3,607.00
|
$3,607.00
|
| EBITDA |
-$9.32 M
|
-$8.04 M
|
-$4.59 M
|
-$1.86 M
|
-$3.42 M
|
-$1.69 M
|
-$1.57 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$436,063.00
|
$215,017.00
|
$27,367.00
|
$832.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$8.89 M |
-$7.83 M |
-$4.57 M |
-$1.86 M |
-$3.43 M |
-$1.69 M |
-$1.57 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$215,017.00 |
-$27,367.00 |
-$832.00 |
$3.00 |
-$157,534.00 |
$3.00 |
| Net Income |
-$8.89 M |
-$7.61 M |
-$4.54 M |
-$1.86 M |
-$3.43 M |
-$1.69 M |
-$1.57 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.69 |
-0.59 |
-0.35 |
-0.15 |
-0.29 |
-0.14 |
-0.13 |
| EPS Diluted |
-0.69 |
-0.59 |
-0.35 |
-0.15 |
-0.29 |
-0.14 |
-0.13 |
| Weighted Average Shares
Out |
$12.85 M
|
$12.91 M
|
$12.94 M
|
$12.70 M
|
$11.74 M
|
$11.97 M
|
$11.74 M
|
| Weighted Average Shares
Out Diluted |
$12.85 M
|
$12.91 M
|
$12.94 M
|
$12.70 M
|
$11.74 M
|
$11.97 M
|
$11.74 M
|
| Link |
|
|
|
|
|
|
|
